Literature DB >> 27508031

miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition.

Hong Zhao1, Xing Kang2, Xuefeng Xia2, Like Wo1, Xidong Gu1, Yuanyuan Hu1, Xiaohong Xie1, Helena Chang3, Lihua Lou1, Xuning Shen4.   

Abstract

MicroRNAs (miRNAs), small non-coding RNAs, regulate fundamental cellular and developmental processes such as cell growth, apoptosis, migration, and invasion. In our present study, we investigated the inhibitory role of miR-145 on breast cancer cell migration as well as its underlying mechanism. Wound healing assay and transwell migration assay showed that ectopic expression of miR-145 significantly inhibited breast cancer cell migration. Bioinformatics analysis revealed that FSCN-1 was a putative target of miR-145. The expression of FSCN-1 varied among four different breast cancer cells, and inversely correlated with miR-145 levels. Moreover, miR-145 mimic transfection enhanced the expression of FSCN-1 in Bcap-37 and HCC-1937 cells. We also found that siRNA- mediated down-regulation of FSCN-1 inhibited cell motility in breast cancer cells. In addition, we found that up-regulation of miR-145 blocked EMT and decreased the expression of MMP-2/9 in breast cancer cells. These results reveal a new link between miR-145, FSCN-1 and EMT in the regulation of breast cancer migration.

Entities:  

Keywords:  Breast cancer; FSCN-1; epithelial-mesenchymal transition; miR-145; migration

Year:  2016        PMID: 27508031      PMCID: PMC4969447     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  33 in total

1.  Breast cancer metastasis: when, where, how?

Authors:  Suzanne A Eccles; Lenaic Paon
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

2.  Fascin, an actin-bundling protein, promotes breast cancer progression in vitro.

Authors:  Peng Xing; Ji-guang Li; Feng Jin; Ting-ting Zhao; Qun Liu; Hui-ting Dong; Xiao-lin Wei
Journal:  Cell Biochem Funct       Date:  2011-06       Impact factor: 3.685

3.  Adjuvant chemotherapy for local relapse breast cancer.

Authors:  Xavier Pivot
Journal:  Lancet Oncol       Date:  2014-01-16       Impact factor: 41.316

4.  Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.

Authors:  Rui-Juan Wang; Yan-Hua Zheng; Ping Wang; Jian-Zhong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.

Authors:  M Götte; C Mohr; C-Y Koo; C Stock; A-K Vaske; M Viola; S A Ibrahim; S Peddibhotla; Y H-F Teng; J-Y Low; K Ebnet; L Kiesel; G W Yip
Journal:  Oncogene       Date:  2010-09-06       Impact factor: 9.867

6.  SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer.

Authors:  Takeshi Chiyomaru; Shuichi Tatarano; Kazumori Kawakami; Hideki Enokida; Hirofumi Yoshino; Nijiro Nohata; Miki Fuse; Naohiko Seki; Masayuki Nakagawa
Journal:  Prostate       Date:  2011-02-25       Impact factor: 4.104

7.  Pathogenesis and vascular integrity of breast cancer brain metastasis.

Authors:  Weixin Lu; Corazon D Bucana; Alan J Schroit
Journal:  Int J Cancer       Date:  2007-03-01       Impact factor: 7.396

8.  Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer.

Authors:  A Grothey; R Hashizume; A A Sahin; P D McCrea
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

9.  MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma.

Authors:  Ying-Qin Li; Qing-Mei He; Xian-Yue Ren; Xin-Ran Tang; Ya-Fei Xu; Xin Wen; Xiao-Jing Yang; Jun Ma; Na Liu
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

Review 10.  Regulation of breast cancer and bone metastasis by microRNAs.

Authors:  S Vimalraj; P J Miranda; B Ramyakrishna; N Selvamurugan
Journal:  Dis Markers       Date:  2013-09-26       Impact factor: 3.434

View more
  25 in total

Review 1.  MiR-145: a potential biomarker of cancer migration and invasion.

Authors:  Wen-Xiu Xu; Zhen Liu; Fei Deng; Dan-Dan Wang; Xing-Wang Li; Tian Tian; Jian Zhang; Jin-Hai Tang
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

Review 2.  Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses.

Authors:  Gabriela Green-Tripp; Callum Nattress; Gunnel Halldén
Journal:  Front Mol Biosci       Date:  2022-06-24

3.  microRNA-143/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancer.

Authors:  Sharon Wang; Jeff C Liu; YoungJun Ju; Giovanna Pellecchia; Veronique Voisin; Dong-Yu Wang; Rajwinder Leha L; Yaacov Ben-David; Gary D Bader; Eldad Zacksenhaus
Journal:  JCI Insight       Date:  2017-08-03

4.  Prognostic significance of FSCN family in multiple myeloma.

Authors:  Cong Deng; Chaozeng Si; Xu Ye; Qiang Zhou; Tiansheng Zeng; Zeyong Huang; Wenhui Huang; Pei Zhu; Qingfu Zhong; Zhihua Wu; Huoyan Zhu; Qing Lin; Wenjuan Zhang; Lin Fu; Yongjiang Zheng; Tingting Qian
Journal:  J Cancer       Date:  2021-01-30       Impact factor: 4.207

Review 5.  Targeting MicroRNAs in Cancer Gene Therapy.

Authors:  Weidan Ji; Bin Sun; Changqing Su
Journal:  Genes (Basel)       Date:  2017-01-09       Impact factor: 4.096

6.  Hsa-miR-599 suppresses the migration and invasion by targeting BRD4 in breast cancer.

Authors:  Yonghui Wang; Yana Sui; Qinwei Zhu; Xiaomei Sui
Journal:  Oncol Lett       Date:  2017-07-21       Impact factor: 2.967

7.  Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration.

Authors:  Asfar S Azmi; Yiwei Li; Irfana Muqbil; Amro Aboukameel; William Senapedis; Erkan Baloglu; Yosef Landesman; Sharon Shacham; Michael G Kauffman; Philip A Philip; Ramzi M Mohammad
Journal:  Oncotarget       Date:  2017-07-17

8.  A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.

Authors:  Maha M Itani; Farah J Nassar; Arafat H Tfayli; Rabih S Talhouk; Ghada K Chamandi; Abdul Rahman S Itani; Joelle Makoukji; Rose-Mary N Boustany; Lifang Hou; Nathalie K Zgheib; Rihab R Nasr
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

9.  Proteomic Characterization of Cytoplasmic Lipid Droplets in Human Metastatic Breast Cancer Cells.

Authors:  Alyssa S Zembroski; Chaylen Andolino; Kimberly K Buhman; Dorothy Teegarden
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244

10.  MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma.

Authors:  Xingqiang Wang; Enqin Wang; Jun Cao; Feng Xiong; Yonglin Yang; Haitao Liu
Journal:  Oncotarget       Date:  2017-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.